Mariner, LLC Opiant Pharmaceuticals, Inc. Transaction History

Mariner, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$9.38 - $20.29 $28,140 - $60,870	-3,000 Reduced 22.14%	10,550 $214,000
Q3 2022 Nov 10, 2022	BUY	$9.52 - $13.48 $128,996 - $182,654	13,550 New	13,550 $146,000
Q2 2022 Aug 15, 2022	SELL	$10.12 - $23.32 $137,126 - $315,986	-13,550 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$19.54 - $33.59 $264,767 - $455,144	13,550 New	13,550 $290,000

300

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

Stay updated on Mariner, LLC with notifications on news.